drugset / Trial / NCT03814135

Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia

NCT03814135 ↗

Phase 2 Withdrawn EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of three doses of Hipnos medication in adults with insomnia.

Timeline

Start
2021-01
Primary completion
2022-02
Completion
2022-03

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject Hipnos Unknown 3 unknown Oral
Subject Hipnos Unknown 5 unknown Oral

Indications